| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |